Our US Grantees

maus marcela

Marcela V. Maus, MD, PhD

Massachusetts General HospitalIdentification and correction of T cell defects in patients with chronic lymphocytic leukemia and impact on T cell therapy....more

marcello rotta

Marcello Rotta

Fred Hutchinson Cancer Research Center New approaches to Haploidentical Hemopoietic Cell Transplant...more

martin caroll

Martin Carroll, M.D.

University of Pennsylvania Medical Center Activation of Signal Transduction Pathways in Leukemia...more

mwalter

Matthew J. Walter, M.D.

Washington University, St. Louis Dynamic Changes in MDS Clonal Architecture During Treatment with Hypomethylating Agents...more

michael major

Michael B. Major, PhD

Assistant Professor Molecular Rationale for WNT Inhibitor Therapy in B-Cell LymphomaUNC Lineberger...more

Nigel Killeen, Ph.D.

University of California, San Francisco The Development of Murine Models of Recurring Myeloid Leukemia-Associated Chromosomal Deficiencies...more

omar abdel wahab

Omar Abdel-Wahab, M.D.

Memorial Sloan-Kettering Cancer Center The Role of ASXL1 mutations in leukemia patients...more

patricia ernst

Patricia Ernst, Ph.D.

Dartmouth Medical School Targeting MLL-Cofactor Interaction to Selectively Block Mixed Lineage Leukemia...more

patrick brown

Patrick Brown, M.D.

Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center Investigating promoter hypermethylation in the biology of MLL-rearranged leukemia, and as a novel...more

paul galardy

Paul J. Galardy, M.D.

Mayo Clinic Exploring the role of UCHL1 in leukemia and lymphoma...more

peiying yang

Pieying Yang, Ph.D.

MD Anderson Cancer Center Fish oil (n-3 fatty acids) and non-Hodgkin lymphoma...more

quingli

Qing Li, M.D., Ph.D.

Regents of the University of Michigan Nras signaling in hematopoietic stem cells and leukemic stem cells...more

richard harvey2

Richard C. Harvey, Ph.D.

University of New Mexico Cancer Research & Treatment Center...more

richard williams

Richard T. Williams, M.D., Ph.D.

St. Jude Children's Research Hospital Systematic, High-Throughput Developmental Therapeutics in High-Risk ALL...more

ronan swords

Ronan T. Swords, M.D.

Sylvester Comprehensive Cancer CenterUniversity of MiamiTargeting NEDD8 protein conjugation: a novel therapeutic strategy for acute lymphoblastic leukemia (ALL)....more

ross levine

Ross L. Levine, M.D.

Memorial Sloan-Kettering Cancer Center Genomic characterizations of myeloproliferative neoplasms...more

r oconnel

Ryan M. O'Connell, PhD

Assistant Professor University of Utah Investigating the collaboration between microRNAs and oncogenes in leukemia...more

gill

Saar I. Gill, MD, PhD

p class="projectTitle">University of Pennsylvania School of Medicine Novel approaches to enhancing the therapeutic index of chimeric antigen receptor T cell...more

parekh11

Samir Parekh, M.D.

Albert Einstein College of MedicineTargeting NOXA methylation to overcome Bortezomib resistance in MCL...more

samuel katz

Samuel Katz, MD, PhD

Yale School of Medicine Cell Death Regulation by Pro-Apoptotic BOK in Multiple Myeloma...more